Abstract
Background Schizophrenia and white blood cell count (WBC) are both complex and polygenic disease/traits. Previous evidence suggested that increased WBC is associated with higher all-cause mortality, and other evidence found elevated WBC in first-episode psychosis and chronic schizophrenia patients. However, prior observational findings may be confounded by antipsychotic exposures and their effects on WBC. Mendelian randomization (MR) is a useful method to examine the directional causal relationship between schizophrenia and WBC
Methods We performed a two-sample MR using summary statistics of the Psychiatric Genomics Consortium Schizophrenia Workgroup (N=130,644) and the Blood Cell Consortium (N=563,085). The MR methods included inverse variance weighted, ME Egger, weighted median, and MR-PRESSO, contamination mixture, and a novel approach called mixture model reciprocal causal inference (MRCI). False discovery rate was employed to correct for multiple testing.
Results After correcting for horizontal pleiotropy, the MRCI method demonstrated that elevated lymphocyte count (causal effects at the liability scale=0.077; FDR adjusted p-value=0.026) and eosinophil count (causal effects at the liability scale=0.048; FDR adjusted p-value=0.026) may cause schizophrenia. The contamination mixture method showed that schizophrenia may lead to elevated neutrophil count (beta=0.011 in unit of standard deviation of mean absolute neutrophil count; FDR adjusted p-value=0.045) and reduction of eosinophil count (beta=-0.013 in unit of standard deviation of mean absolute eosinophil count; FDR adjusted p-value=0.045). Some further significant findings had been identified by conventional MR approaches and MR-PRESSO, but we interpreted those with cautious due to substantial heterogeneity and plausible pleiotropic effects identified.
Conclusion This MR study provided evidence that schizophrenia has causal relationships with altered differential WBC. Our findings support the role of WBC in influencing schizophrenia risk, and may concur with the hypothesis of neuroinflammation in schizophrenia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by HKU Seed Fund for Basic Research for New Staff (202009185071) and the HKU Enhanced Start-up Fund for New Staff granted to Simon SY Lui.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Discussion section was further elaborated, and several typos were fixed, but the results of this study are unchanged.
Data Availability
All data produced are available online at Psychiatric Genomic Consortium and IEU Open GWAS Project
